BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• Business

  Juno Therapeutics to Report Third Quarter 2017 Financial Results on Wednesday, November 1

  Juno Therapeutics, Inc. will announce financial results for the third quarter 2017 on Wednesday, November 1, 2017, after the close of U.S.-based financial markets.

  October 25, 2017

   · 

  4 min read
• Drug Development

  Anika Completes Enrollment in Second Pivotal Phase III Trial of CINGAL for the Treatment of Knee Pain Associated With Osteoarthritis

  Anika Therapeutics today announced the completion of enrollment in its second pivotal Phase III trial evaluating CINGAL, its novel HA-corticosteroid combination viscosupplement1 for the treatment of symptoms associated with osteoarthritis (“OA”) of the knee.

  October 25, 2017

   · 

  5 min read
• Business

  Anika Reports Third Quarter 2017 Financial Results

  Anika Therapeutics, Inc. reported financial results for the third quarter ended September 30, 2017, along with business progress in the period.

  October 25, 2017

   · 

  11 min read
• Business

  Vertex Reports Third-Quarter 2017 Financial Results

  Vertex Pharmaceuticals Incorporated today reported consolidated financial results for the third quarter ended September 30, 2017.

  October 25, 2017

   · 

  30 min read
• Business

  Exactech Cancels Q3 Earnings Call Previously Scheduled for Tuesday, October 31, 2017

  Exactech announced today that, due to its definitive agreement with TPG Capital to go private, the company will not hold the Third Quarter conference call previously scheduled for Tuesday, October 31, 2017.

  October 25, 2017

   · 

  2 min read
• Lone Star Bio

  CoorsTek Medical Announces the First Human Implantation of a New, State-of-the-Art Sacroiliac Fusion System

  CoorsTek Medical announced the first human implantation of a new generation of MIS Sacroiliac fusion implants.

  October 25, 2017

   · 

  2 min read
• Deals

  Endo Completes Divestiture of Grupo Farmaceutico SOMAR

  Endo International today announced the completion of the previously announced sale of Grupo Farmaceutico SOMAR to Advent International for a purchase price of approximately $124M.

  October 25, 2017

   · 

  2 min read
• Business

  PDL BioPharma to Announce Third Quarter 2017 Financial Results on November 2, 2017

  PDL BioPharma today announced that the Company will release its third quarter financial results for the period ended September 30, 2017, on Thursday, November 2, 2017, after market close.

  October 25, 2017

   · 

  2 min read
• Policy

  MabSpace Biosciences Submits Investigational New Drug Application for Its Second Generation PD-L1 Antibody With pH-Dependent Antigen Binding Property

  MabSpace Biosciences announced it has filed an IND application to CFDA on September 12th, 2017 for MSB2311, a second-generation PD-L1 antibody with pH-dependent antigen binding property.

  October 25, 2017

   · 

  2 min read
• Business

  Novoheart Holdings Inc. Reports Fourth Quarter and Fiscal 2017 Financial Results

  Novoheart Holdings Inc. today announced financial results for the three and twelve months ended June 30, 2017.

  October 25, 2017

   · 

  17 min read